The therapeutic use of doxorubicin (an antitumoral antibiotic belonging to the anthracycline group) is limited by its cardiotoxicity. Adriamycin (DXR) causes myocardial subcellular damage, such as myocytolysis, disarray of actin filaments, and alterations in the Z-band with loss of sarcomeric organization. We studied the effect of stoichiometrical concentrations of DXR on the interaction between cardiac actin and α-actinin in solution. Doxorubicin inhibits the formation of α-actinin/actin tridimensional networks and bundles. The main effect of the drug seems to be on the size of the actin polymers.
Interaction of cardiac alpha-actinin and actin in the presence of doxorubicin / I. Dalle Donne, A. Milzani, P. Contini, G. Bernardini, R. Colombo. - In: EXPERIMENTAL AND MOLECULAR PATHOLOGY. - ISSN 0014-4800. - 56:3(1992), pp. 229-238.
Interaction of cardiac alpha-actinin and actin in the presence of doxorubicin
I. Dalle DonnePrimo
;A. MilzaniSecondo
;
1992
Abstract
The therapeutic use of doxorubicin (an antitumoral antibiotic belonging to the anthracycline group) is limited by its cardiotoxicity. Adriamycin (DXR) causes myocardial subcellular damage, such as myocytolysis, disarray of actin filaments, and alterations in the Z-band with loss of sarcomeric organization. We studied the effect of stoichiometrical concentrations of DXR on the interaction between cardiac actin and α-actinin in solution. Doxorubicin inhibits the formation of α-actinin/actin tridimensional networks and bundles. The main effect of the drug seems to be on the size of the actin polymers.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dalle-Donne 1992 EMP.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.6 MB
Formato
Adobe PDF
|
1.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
